Levofloxacin in treating infective disease in 60 patients
Abstract
AIM: To study the efficiency of levofloxacin and compare with ciprofloxacin in treating infective disease. METHODS: Ninety patients with infective disease were divided into two groups. The levofloxacin group of 60 patients (M 38, F 22; age 67 a±s 10 a) were treated with levofloxacin lactate injection. Among them the thirty patients were given 200 mg qd, and another thirty patients were given 100 mg bid. The control group of 30 patients (M 13,F 17; age 57 a±6 a) were given ciprofloxacin lactate injection 200 mg bid. Three groups all given by iv, drip×714d. RESULTS: The cure rates were 85 % in levofloxacin group and 53 % in the control group (P0.05). The cure rates and effective rates were 83 % and 97 % in the first thirty patients and 87 % and 90 % in the second thirty patients (P 0.05). CONCLUSION: Lavofloxacin have better effective than ciprofloxacin in the treatment of infective disease, and the similar efficiency can be observed with the same dose·d -1 qd or bid.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.